Pharmacy practice and education vary greatly across the world.
November 2013
Bloxiverz, manufactured by Éclat Pharmaceuticals, is the first and only FDA-approved neostigmine methylsulfate injection.
A guide to treatment of rheumatoid arthritis, the most common chronic inflammatory joint disease.
A discussion of current and emerging pharmacotherapy options for cystic fibrosis patients.
A case involving a 43-year-old female with a history of type 2 diabetes who is admitted for hyperglycemia as well as complaints of dysuria and increased urinary frequency.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
4
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
5
